These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 8346511)

  • 1. [Analgesics; the use of aspirin in dogs; effects of tablet type and food intake on plasma salicylate level].
    Nap RC; Breen DJ; Lam TJ; Peters IO; Willemsen A; De Bruyne JJ
    Tijdschr Diergeneeskd; 1993 Jul; 118(13):439-42. PubMed ID: 8346511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric retention of enteric-coated aspirin tablets in beagle dogs.
    Nap RC; Breen DJ; Lam TJ; De Bruyne JJ
    J Vet Pharmacol Ther; 1990 Jun; 13(2):148-53. PubMed ID: 2384905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum salicylate concentrations and endoscopic evaluation of the gastric mucosa in dogs after oral administration of aspirin-containing products.
    Lipowitz AJ; Boulay JP; Klausner JS
    Am J Vet Res; 1986 Jul; 47(7):1586-9. PubMed ID: 3740630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of aspirin and its application in canine veterinary medicine.
    Morton DJ; Knottenbelt DC
    J S Afr Vet Assoc; 1989 Dec; 60(4):191-4. PubMed ID: 2487727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady-state plasma levels of salicylate in patients with rheumatoid arthritis: effects of dosing interval and tablet strength.
    Keystone EC; Paton TW; Littlejohn G; Verdejo A; Piper S; Wright LA; Goldsmith CH
    Can Med Assoc J; 1982 Aug; 127(4):283-6. PubMed ID: 7093867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enteric aspirin tablets and the salicylate concentration in the plasma in the morning].
    Laine V; Strandman D; Tikkanen R
    Lakartidningen; 1968 Sep; 65(39):3832-7 passim. PubMed ID: 5741894
    [No Abstract]   [Full Text] [Related]  

  • 9. Application of a radiotelemetric system to evaluate the performance of enteric coated and plain aspirin tablets.
    Lui CY; Oberle R; Fleisher D; Amidon GL
    J Pharm Sci; 1986 May; 75(5):469-74. PubMed ID: 3735085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability.
    Portek I; Graham G; Fleming A
    Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of enteric coating of aspirin tablets on occult gastrointestinal blood loss.
    Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG
    Aust N Z J Med; 1977 Dec; 7(6):600-4. PubMed ID: 350214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations.
    Schwertner HA; McGlasson D; Christopher M; Bush AC
    Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salicylate-induced gastrointestinal bleeding: comparison between soluble buffered, enteric-coated, and intravenous administration.
    Mielants H; Verbruggen G; Schelstraete K; Veys EM
    J Rheumatol; 1979; 6(2):210-8. PubMed ID: 313448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twice-daily dosing of enteric-coated aspirin in patients with rheumatic diseases.
    Bensen WG; Laskin CA; Paton TW; Little HA; Fam AG
    J Rheumatol; 1979; 6(3):351-9. PubMed ID: 314982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin dosing using 15 grain enteric coated tablets.
    Pollet S; White RH; Jang H; Yim CW; Feigal D
    J Rheumatol; 1985 Apr; 12(2):337-42. PubMed ID: 4032405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose evaluation of a new enteric-coated aspirin preparation.
    Paull P; Day R; Graham G; Champion D
    Med J Aust; 1976 Apr; 1(17):617-9. PubMed ID: 933973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative bioavailability of sustained-release and uncoated aspirin tablets.
    Karahalios WJ; Sawyer WT; Rittase RA; Maynard SA
    Am J Hosp Pharm; 1981 Nov; 38(11):1754-6. PubMed ID: 7304632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms.
    Bogentoft C; Carlsson I; Ekenved G; Magnusson A
    Eur J Clin Pharmacol; 1978 Dec; 14(5):351-5. PubMed ID: 32046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin dosages for the dog.
    Yeary RA; Brant RJ
    J Am Vet Med Assoc; 1975 Jul; 167(1):63-4. PubMed ID: 1150495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of pharmacokinetic and pharmacodynamic profiles of aspirin following oral gavage and diet dosing in rats.
    Kapetanovic IM; Bauer KS; Tessier DM; Lindeblad MO; Zakharov AD; Lubet R; Lyubimov A
    Chem Biol Interact; 2009 May; 179(2-3):233-9. PubMed ID: 18992230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.